Methods of Treating Eye Disorders with APLNR Antagonists and VEGF Inhibitors

• 收藏
• 分享

专利权人:

Regeneron Pharmaceutical; Inc.

发明人:

Jingtai CAO,Eunice CHEUNG,Ivan B. LOBOV

申请号：

US15972053

公开号：

US20180251545A1

申请日:

2018.05.04

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present disclosure provides methods for treating, preventing or reducing the severity of an eye disease. The methods of the present disclosure comprise administering to a subject in need thereof a therapeutic composition comprising an APLNR antagonist such as an anti-APLNR antibody in combination with a vascular endothelial growth factor (VEGF) antagonist (for example, aflibercept).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/